Medication Adherence and the Risk of Cardiovascular Mortality and Hospitalization among Patients with Newly Prescribed Antihypertensive Medications

Hypertension

Volumn 67, Issue 3, 2016, Pages 506-512

  Kim, Soyeun ^a   Shin, Dong Wook ^b,c   Yun, Jae Moon ^b,c   Hwang, Yunji ^f,g,h   Park, Sue K ^f,g,h   Ko, Young Jin ^a   Cho, Belong ^b,c,d,e,h  

^a Korea Cancer Center Hospital   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University Cancer Hospital   (South Korea)

^d Seoul National University   (South Korea)

^e Institute on Aging   (United States)

^f Department of Preventive Medicine ^*  (United States)

^g Seoul National University College of Medicine   (South Korea)

^h Seoul National University   (South Korea)

Author keywords

antihypertensive agents; cerebral hemorrhage; hospitalization; medication adherence; stroke

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PRESCRIPTION DRUG;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; BRAIN INFARCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; NATIONAL HEALTH INSURANCE; PATIENT COMPLIANCE; PRIORITY JOURNAL; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED STUDY; EPIDEMIOLOGY; MORTALITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SOUTH KOREA; SURVIVAL RATE; TRENDS;

AGED; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PRESCRIPTION DRUGS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE;

EID: 84958051638     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.06731     Document Type: Article

References (41)

1. Lawes CM, Vander Hoorn S, Rodgers A; International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet. 2008; 371: 1513-1518. doi: 10.1016/S0140-6736(08)60655-8.
2. Turnbull F, Neal B, Ninomiya T, Algert C, Arima H, Barzi F, Bulpitt C, Chalmers J, Fagard R, Gleason A, Heritier S, Li N, Perkovic V, Woodward M, MacMahon S. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ. 2008; 336: 1121-1123.
3. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009; 338: b1665.
4. Law M, Wald N, Morris J. Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy. Health Technol Assess. 2003; 7: 1-94.
5. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005; 353: 487-497. doi: 10.1056/NEJMra050100.
6. Burke TA, Sturkenboom MC, Lu SE, Wentworth CE, Lin Y, Rhoads GG. Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice. J Hypertens. 2006; 24: 1193-1200. doi: 10.1097/01.hjh.0000226211.95936.f5.
7. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002; 288: 455-461.
8. Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ. 2008; 336: 1114-1117. doi: 10.1136/bmj.39553.670231.25.
9. Mazzaglia G, Mantovani LG, Sturkenboom MC, Filippi A, Trifirò G, Cricelli C, Brignoli O, Caputi AP. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hypertens. 2005; 23: 2093-2100.
10. Sung SK, Lee SG, Lee KS, Kim DS, Kim KH, Kim KY. First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review. Clin Ther. 2009; 31: 1309-1320. doi: 10.1016/j.clinthera.2009.06.011.
11. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002; 40: 794-811. doi: 10.1097/01.MLR.0000024612.61915.2D.
12. Shin S, Song H, Oh SK, Choi KE, Kim H, Jang S. Effect of antihypertensive medication adherence on hospitalization for cardiovascular disease and mortality in hypertensive patients. Hypertens Res. 2013; 36: 1000-1005. doi: 10.1038/hr.2013.85.
13. Wu PH, Yang CY, Yao ZL, Lin WZ, Wu LW, Chang CC. Relationship of blood pressure control and hospitalization risk to medication adherence among patients with hypertension in Taiwan. Am J Hypertens. 2010; 23: 155-160. doi: 10.1038/ajh.2009.210.
14. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005; 43: 521-530.
15. Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, Borghi C, Brignoli O, Caputi AP, Cricelli C, Mantovani LG. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009; 120: 1598-1605. doi: 10.1161/CIRCULATIONAHA.108.830299.
16. Pittman DG, Tao Z, Chen W, Stettin GD. Antihypertensive medication adherence and subsequent healthcare utilization and costs. Am J Manag Care. 2010; 16: 568-576.
17. Wong MC, Tam WW, Cheung CS, Wang HH, Tong EL, Sek AC, Yan BP, Cheung NT, Leeder S, Yu CM, Griffiths S. Drug adherence and the incidence of coronary heart disease- and stroke-specific mortality among 218, 047 patients newly prescribed an antihypertensive medication: a five-year cohort study. Int J Cardiol. 2013; 168: 928-933. doi: 10.1016/j. ijcard.2012.10.048.
18. Park JH, Shin Y, Lee SY, Lee SI. Antihypertensive drug medication adherence and its affecting factors in South Korea. Int J Cardiol. 2008; 128: 392-398. doi: 10.1016/j.ijcard.2007.04.114.
19. Park JH, Park JH, Lee SY, Kim SY, Shin Y, Kim SY. Disparities in antihypertensive medication adherence in persons with disabilities and without disabilities: results of a Korean population-based study. Arch Phys Med Rehabil. 2008; 89: 1460-1467. doi: 10.1016/j.apmr.2007.12.045.
20. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997; 50: 105-116.
21. Grant RW, Singer DE, Meigs JB. Medication adherence before an increase in antihypertensive therapy: a cohort study using pharmacy claims data. Clin Ther. 2005; 27: 773-781. doi: 10.1016/j.clinthera.2005.06.004.
22. Grymonpre R, Cheang M, Fraser M, Metge C, Sitar DS. Validity of a prescription claims database to estimate medication adherence in older persons. Med Care. 2006; 44: 471-477. doi: 10.1097/01.mlr.0000207817.32496.cb.
23. Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006; 15: 565-574.
24. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin. 2009; 25: 2303-2310. doi: 10.1185/03007990903126833.
25. Zanchetti A, Thomopoulos C, Parati G. Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal. Circ Res. 2015; 116: 1058-1073. doi: 10.1161/CIRCRESAHA.116.303641.
26. Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, Januel JM, Sundararajan V. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011; 173: 676-682. doi: 10.1093/aje/kwq433.
27. Wang JG, Li Y. Primary and secondary prevention of stroke by antihypertensive drug treatment. Expert Rev Neurother. 2004; 4: 1023-1031. doi: 10.1586/14737175.4.6.1023.
28. Staessen JA, Li Y, Thijs L, Wang JG. Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials. Hypertens Res. 2005; 28: 385-407. doi: 10.1291/hypres.28.385.
29. Degli Esposti L, Saragoni S, Benemei S, Batacchi P, Geppetti P, Di Bari M, Marchionni N, Sturani A, Buda S, Degli Esposti E. Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients. Clinicoecon Outcomes Res. 2011; 3: 47-54. doi: 10.2147/CEOR.S15619.
30. Liu Q, Quan H, Chen G, Qian H, Khan N. Antihypertensive medication adherence and mortality according to ethnicity: a cohort study. Can J Cardiol. 2014; 30: 925-931. doi: 10.1016/j.cjca.2014.04.017.
31. Corrao G, Parodi A, Nicotra F, Zambon A, Merlino L, Cesana G, Mancia G. Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens. 2011; 29: 610-618. doi: 10.1097/HJH.0b013e328342ca97.
32. Dragomir A, C?té R, Roy L, Blais L, Lalonde L, Bérard A, Perreault S. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Med Care. 2010; 48: 418-425. doi: 10.1097/MLR.0b013e3181d567bd.
33. Kettani FZ, Dragomir A, C?té R, Roy L, Bérard A, Blais L, Lalonde L, Moreau P, Perreault S. Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention. Stroke. 2009; 40: 213-220. doi: 10.1161/STROKEAHA.108.522193.
34. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007; 297: 177-186. doi: 10.1001/jama.297.2.177.
35. Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, Magid DJ. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006; 166: 1836-1841. doi: 10.1001/archinte.166.17.1836.
36. Gislason GH, Rasmussen JN, Abildstrom SZ, Schramm TK, Hansen ML, Buch P, S?rensen R, Folke F, Gadsb?ll N, Rasmussen S, K?ber L, Madsen M, Torp-Pedersen C. Persistent use of evidence- based pharmacotherapy in heart failure is associated with improved outcomes. Circulation. 2007; 116: 737-744. doi: 10.1161/CIRCULATIONAHA.106.669101.
37. Fisher LD, Lin DY. Time-dependent covariates in the Cox proportionalhazards regression model. Annu Rev Public Health. 1999; 20: 145-157. doi: 10.1146/annurev.publhealth.20.1.145.
38. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009; 119: 3028-3035. doi: 10.1161/CIRCULATIONAHA.108.768986.
39. Bullano MF, Kamat S, Willey VJ, Barlas S, Watson DJ, Brenneman SK. Agreement between administrative claims and the medical record in identifying patients with a diagnosis of hypertension. Med Care. 2006; 44: 486-490. doi: 10.1097/01.mlr.0000207482.02503.55.
40. EURopean Trial on Reduction of Cardiac Events With Perindopril in Stable Coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). The Lancet. 2003; 362: 782-788.
41. Thompson AM, Hu T, Eshelbrenner CL, Reynolds K, He J, Bazzano LA. Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis. JAMA. 2011; 305: 913-922. doi: 10.1001/jama.2011.250.